Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Omnicell, Inc. (NASDAQ:OMCL - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven brokerages that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $44.83.

OMCL has been the subject of a number of research reports. JPMorgan Chase & Co. reduced their price objective on Omnicell from $44.00 to $36.00 and set a "neutral" rating for the company in a research report on Thursday, March 20th. Wall Street Zen upgraded Omnicell from a "hold" rating to a "buy" rating in a research report on Tuesday, May 20th. Piper Sandler reiterated an "overweight" rating on shares of Omnicell in a research report on Friday, May 23rd. Bank of America upped their price target on Omnicell from $30.00 to $34.00 and gave the stock a "neutral" rating in a research report on Friday, May 23rd. Finally, Benchmark reduced their price target on Omnicell from $62.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th.

Institutional Investors Weigh In On Omnicell

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Smartleaf Asset Management LLC raised its position in Omnicell by 51.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 803 shares of the company's stock valued at $35,000 after purchasing an additional 273 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Omnicell in the fourth quarter worth approximately $37,000. Van ECK Associates Corp raised its holdings in shares of Omnicell by 47.0% in the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company's stock worth $44,000 after buying an additional 315 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Omnicell in the fourth quarter worth approximately $53,000. Finally, First Horizon Advisors Inc. raised its holdings in shares of Omnicell by 36.3% in the fourth quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company's stock worth $59,000 after buying an additional 355 shares during the period. 97.70% of the stock is currently owned by hedge funds and other institutional investors.

Omnicell Trading Down 0.8%

Omnicell stock opened at $28.03 on Friday. The company has a current ratio of 1.38, a quick ratio of 1.23 and a debt-to-equity ratio of 0.13. The business's fifty day simple moving average is $29.45 and its two-hundred day simple moving average is $36.36. Omnicell has a 12 month low of $22.66 and a 12 month high of $55.75. The company has a market capitalization of $1.31 billion, a price-to-earnings ratio of 60.94 and a beta of 0.78.

Omnicell (NASDAQ:OMCL - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.10. Omnicell had a return on equity of 4.60% and a net margin of 1.87%. The firm had revenue of $269.67 million during the quarter, compared to analysts' expectations of $260.18 million. During the same quarter in the previous year, the business earned $0.03 earnings per share. The company's revenue was up 9.5% on a year-over-year basis. As a group, equities analysts predict that Omnicell will post 1.09 earnings per share for the current fiscal year.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.